Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INNOVATE (VATE) Total Liabilities: 2009-2025

Historic Total Liabilities for INNOVATE (VATE) over the last 15 years, with Sep 2025 value amounting to $1.1 billion.

  • INNOVATE's Total Liabilities rose 9.62% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 9.62%. This contributed to the annual value of $1.0 billion for FY2024, which is 12.30% down from last year.
  • According to the latest figures from Q3 2025, INNOVATE's Total Liabilities is $1.1 billion, which was up 3.77% from $1.1 billion recorded in Q2 2025.
  • INNOVATE's Total Liabilities' 5-year high stood at $6.4 billion during Q2 2021, with a 5-year trough of $1.0 billion in Q2 2024.
  • Over the past 3 years, INNOVATE's median Total Liabilities value was $1.1 billion (recorded in 2025), while the average stood at $1.1 billion.
  • In the last 5 years, INNOVATE's Total Liabilities slumped by 82.50% in 2021 and then grew by 10.54% in 2022.
  • INNOVATE's Total Liabilities (Quarterly) stood at $1.1 billion in 2021, then rose by 10.54% to $1.2 billion in 2022, then dropped by 0.12% to $1.2 billion in 2023, then declined by 12.30% to $1.0 billion in 2024, then rose by 9.62% to $1.1 billion in 2025.
  • Its Total Liabilities stands at $1.1 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $1.0 billion for Q1 2025.